4/A//SEC Filing
McKesson Ventures, LLC 4/A
Accession 0001062993-22-019796
CIK 0001769804other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 6:17 PM ET
Size
5.4 KB
Accession
0001062993-22-019796
Insider Transaction Report
Form 4/AAmended
Augmedix, Inc.AUGX
McKesson Ventures, LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2021-10-28$4.00/sh+112,500$450,000→ 4,047,606 total
Footnotes (1)
- [F1]These securities are held of record by McKesson Ventures LLC ("McKesson"). Jennifer M. Carter, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. As a result, McKesson is a director by deputization for Section 16 purposes.
Issuer
Augmedix, Inc.
CIK 0001769804
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001827312
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 6:17 PM ET
- Size
- 5.4 KB